GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 4SC AG (FRA:VSC) » Definitions » FCF Margin %

4SC AG (FRA:VSC) FCF Margin % : 0.00% (As of Jun. 2024)


View and export this data going back to 2005. Start your Free Trial

What is 4SC AG FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. 4SC AG's Free Cash Flow for the six months ended in Jun. 2024 was €0.00 Mil. 4SC AG's Revenue for the six months ended in Jun. 2024 was €0.18 Mil. Therefore, 4SC AG's FCF Margin % for the quarter that ended in Jun. 2024 was 0.00%.

As of today, 4SC AG's current FCF Yield % is -12.13%.

The historical rank and industry rank for 4SC AG's FCF Margin % or its related term are showing as below:

FRA:VSC' s FCF Margin % Range Over the Past 10 Years
Min: -3141.45   Med: -492.11   Max: -85.78
Current: -2660.17


During the past 13 years, the highest FCF Margin % of 4SC AG was -85.78%. The lowest was -3141.45%. And the median was -492.11%.

FRA:VSC's FCF Margin % is ranked worse than
82.95% of 1038 companies
in the Biotechnology industry
Industry Median: -141.315 vs FRA:VSC: -2660.17


4SC AG FCF Margin % Historical Data

The historical data trend for 4SC AG's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4SC AG FCF Margin % Chart

4SC AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -584.34 -698.49 -85.78 -2,152.75 -3,141.45

4SC AG Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4,774.86 -393.49 - - -

Competitive Comparison of 4SC AG's FCF Margin %

For the Biotechnology subindustry, 4SC AG's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


4SC AG's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 4SC AG's FCF Margin % distribution charts can be found below:

* The bar in red indicates where 4SC AG's FCF Margin % falls into.



4SC AG FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

4SC AG's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-9.55/0.304
=-3,141.45 %

4SC AG's FCF Margin for the quarter that ended in Jun. 2024 is calculated as

FCF Margin=Free Cash Flow (Q: Jun. 2024 )/Revenue (Q: Jun. 2024 )
=0/0.182
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


4SC AG FCF Margin % Related Terms

Thank you for viewing the detailed overview of 4SC AG's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


4SC AG Business Description

Traded in Other Exchanges
Address
Fraunhoferstrasse 22, Planegg-Martinsried, DEU, 82152
4SC AG is a clinical-stage biopharmaceutical company developing small-molecule drugs that can target key indications in cancer with high unmet medical needs. Its pipeline is protected by a comprehensive portfolio of patents and currently comprises two drug candidates in clinical development resminostat and Domatinostat. The geographic area of the company is Germany, the EU, and Other countries, and the majority of the revenue comes from Other Countries.

4SC AG Headlines

No Headlines